Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wolff

Showing results (921-930 of 973) with videos related to

Pageof 98
Sort By:
JAMA Surgery|July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal AdenocarcinomaJordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Cancer Research Communications|November 16, 2022
Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancerVan K Morris, Michael J Overman, Michael Lam, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2021
Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating StudyStacy A Rudnicki, Jinsy A Andrews, Tina Duong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2017
Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular CarcinomaManal M Hassan, Gehan Botrus, Reham Abdel-Wahab, et al.
Endoscopic Ultrasound|November 1, 2019
An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocolManoop S Bhutani, Jason B Klapman, Richard Tuli, et al.
JAMA Network Open|October 14, 2022
Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal CancerJennifer S Davis, Janelle C Chavez, Melissa Kok, et al.
The Journal of Clinical Investigation|March 12, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and responseEugene J Koay, Mark J Truty, Vittorio Cristini, et al.
Cancers|October 16, 2024
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case SeriesAshwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, et al.
Lancet (London, England)|August 23, 2011
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trialJohn G F Cleland, John R Teerlink, Roxy Senior, et al.
Journal for Immunotherapy of Cancer|January 30, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinomaEileen M O'Reilly, Christopher R Cabanski, Jaclyn P Lyman, et al.
Pageof 98

Showing results (921-930 of 973) with videos related to

Sort By:
Pageof 98
JAMA Surgery|July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal AdenocarcinomaJordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Cancer Research Communications|November 16, 2022
Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancerVan K Morris, Michael J Overman, Michael Lam, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2021
Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating StudyStacy A Rudnicki, Jinsy A Andrews, Tina Duong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2017
Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular CarcinomaManal M Hassan, Gehan Botrus, Reham Abdel-Wahab, et al.
Endoscopic Ultrasound|November 1, 2019
An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocolManoop S Bhutani, Jason B Klapman, Richard Tuli, et al.
JAMA Network Open|October 14, 2022
Association of Prediagnosis Obesity and Postdiagnosis Aspirin With Survival From Stage IV Colorectal CancerJennifer S Davis, Janelle C Chavez, Melissa Kok, et al.
The Journal of Clinical Investigation|March 12, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and responseEugene J Koay, Mark J Truty, Vittorio Cristini, et al.
Cancers|October 16, 2024
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case SeriesAshwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, et al.
Lancet (London, England)|August 23, 2011
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trialJohn G F Cleland, John R Teerlink, Roxy Senior, et al.
Journal for Immunotherapy of Cancer|January 30, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinomaEileen M O'Reilly, Christopher R Cabanski, Jaclyn P Lyman, et al.
Pageof 98